An interesting article from the Journal of Clinical Sleep Medicine (Jan 24, 2023) doi.org/10.5664/jcsm.10440
I'm unable to access the full article but here's part of the abstract.
STUDY OBJECTIVES:Periodic limb movements during sleep (PLMS) are a frequent finding in restless legs syndrome (RLS), but their impact on sleep is still debated, as well the indication for treatment.
We systematically reviewed the available literature to describe which drug categories are effective in suppressing PLMS, assessing their efficacy through a meta-analysis, when this was possible.
RESULTS:Dopamine agonists like pramipexole and ropinirole resulted the most effective, followed by L-Dopa and other dopamine agonists. Alpha2delta ligands are moderately effective as well opioids, despite available data on these drugs are much more limited than those on dopaminergic agents. Valproate and carbamazepine did not show a significant effect on PLMS. Clonazepam showed contradictory results. Perampanel and dypiridamole showed promising but still insufficient data. The same applies to iron supplementation.
CONCLUSIONS:Dopaminergic agents are the most powerful suppressors of PLMS. However, most therapeutic trials in RLS do not report objective polysomnographic findings, there’s a lack of uniformity in presenting results on PLMS. Longitudinal polysomnographic interventional studies, using well-defined and unanimous scoring criteria and endpoints on PLMS are needed.